30-Oct-2026 18:38:39
PRAJ INDUSTRIES Q2 CONCALL: TARGETS GENX PBT BREAKEVEN WITHIN 12 MONTHS ON ₹500–600 CR REVENUE; PLANS ₹100 CR INVESTMENT IN BPCL CBG JV, SEES ₹1,000 CR INTERNATIONAL BIOENERGY PIPELINE & RETAINS FY30 GROWTH AMBITION
• GenX Breakeven Guidance: Management expects the GenX business to achieve PBT breakeven within the next 12 months, supported by increasing order inflows and higher capacity utilization. • GenX Revenue Requirement: Management estimates approximately ₹500–600 Cr annual revenue is required to achieve PBT breakeven, depending on the mix of equipment, modules and data center orders. • GenX Order Booking Outlook: Management indicated that FY27 order bookings remain broadly in line with earlier expectations, although revenue recognition will depend on execution timelines. • GenX Revenue Ramp-Up: Management expects order execution and revenue contribution to accelerate during H2 FY27, with new orders beginning to contribute from Q3 and Q4. • GenX Customer Approvals: Mangalore manufacturing facility has received approvals from 18 international customers, with four framework agreements operationalized. • GenX Business Opportunities: Company is pursuing large equipment and modular fabrication orders across oil and gas, fertilizers, LNG and data center applications. • GenX Data Center Orders: Management confirmed additional orders during Q2 from an existing customer under an approximately $52 million arrangement spanning two-and-a-half years. • Data Center Revenue Opportunity: Company is supplying precision-fabricated server-support frames and developing specialized cooling-system piping for hyperscale data centers. • GenX Capacity Expansion: Company has seven manufacturing sheds at Mangalore, with two currently equipped and operational. Additional sheds can be activated as orders increase. • GenX Incremental Capex: Management does not anticipate major additional capital expenditure for activating existing sheds, although some equipment investments may be required. • GenX Operating Costs: Management indicated that annual costs, including interest and depreciation, could be approximately ₹140–150 Cr for FY27. • GenX Margin Outlook: Management expects improving revenue and capacity utilization to support EBITDA margin recovery. It agreed that Q2's approximately 6.2% EBITDA margin represents a likely bottom, without providing a firm future margin target. • International Bioenergy Pipeline: Management sees an opportunity pipeline of approximately ₹1,000 Cr developing over the next few quarters, excluding GenX opportunities. • International Expansion: Company is pursuing ethanol-related opportunities in the US, Brazil, Argentina, Southeast Asia and Africa, supported by increasing biofuel blending requirements. • H2 Order Inflow Outlook: Management expects stronger order bookings during H2 FY27, supported by compressed biogas, international bioenergy projects and GenX equipment orders. • Domestic Ethanol Outlook: Management indicated that new greenfield ethanol projects remain subdued, while brownfield expansion, plant efficiency improvement and feedstock diversification are generating opportunities. • Ethanol Feedstock Diversification: Customers are increasingly evaluating grain-processing modules for existing sugar-based ethanol plants to improve operational flexibility and profitability. • Ethanol Project Execution: Management expects greater clarity on delayed domestic ethanol projects by FY27-end, as customers assess funding constraints and feedstock-related policy changes. • E100 Ethanol Opportunity: Management highlighted the legal recognition of E100 fuel for certified flex-fuel vehicles as a potential long-term driver of ethanol capacity expansion. • CBG Joint Venture Investment: Board granted in-principle approval for Praj to invest up to ₹100 Cr through a proposed joint venture with Bharat Petroleum Corporation (BPCL). • CBG JV Structure: Management indicated a proposed 50:50 joint venture, with Praj and BPCL potentially contributing ₹100 Cr each. • CBG JV Formation Timeline: Management expects the joint venture to be established within approximately 2–3 months, after which project execution can begin. • CBG Plant Expansion: The proposed JV could develop approximately 8–10 compressed biogas plants, depending on individual project capacities and financing arrangements. • CBG Project Investment: Management estimated total investment of approximately ₹800–1,000 Cr for a theoretical portfolio of 10 plants, including funding beyond the partners' equity contributions. • CBG Execution Timeline: Management expects the planned plants to be developed in phases over approximately 2–3 years. • First CBG Plant Commissioning: Management expects the first project to require approximately 12 months of execution after JV formation, implying commercial production in around 15 months. • CBG Project Identification: Company has already shortlisted potential projects and is engaging with feedstock suppliers ahead of formal JV incorporation. • CBG Revenue Model: Praj expects revenue from engineering and project execution, while gas sales and related operating revenue will be recognized at the JV level. • CBG Profitability Outlook: Management believes the revised GOBARdhan policy, improved gas offtake arrangements and feedstock flexibility support more attractive project economics, but has not provided a numerical ROI target. • CBG Market Opportunity: Management sees a potential market worth thousands of crores over the next 5–10 years, subject to project viability, financing and infrastructure development. • Multi-Feedstock CBG Technology: Company is focusing on plants capable of processing multiple feedstocks, including press mud, rice straw and Napier grass, to support year-round operations. • CBG Co-Product Opportunities: Management highlighted the potential to improve project returns through organic manure and other biomass-derived products, including bio-based bitumen applications. • Bio-Isobutanol Project: India's first bio-isobutanol plant designed and engineered by Praj is progressing, with construction expected to be completed by the end of 2026. • Bio-Isobutanol Commercialization: Management expects initial commercialization and scale-up demonstrations around the beginning of 2027, while diesel-engine blending trials continue. • Bio-Isobutanol Policy Dependence: Management clarified that broader adoption depends on engine-testing outcomes and government blending policies, which remain outside the company's control. • Sustainable Aviation Fuel: Detailed engineering work for an international ethanol-to-SAF project is progressing, with the customer's final investment decision expected in Q1 FY28. • SAF Revenue Opportunity: A favorable investment decision could create opportunities for Praj to supply additional equipment and modules for plant construction. • Lifecycle Services Growth: Management reported continued sequential growth in maintenance services, plant performance optimization, spare parts, digital services and operations support. • Process Engineering Opportunities: Management sees potential demand from semiconductor, battery and solar manufacturing facilities for high-purity water and zero-liquid-discharge systems. • FY30 Revenue Ambition: Management reiterated its intention to pursue the previously communicated ₹10,000 Cr annual revenue ambition for FY30, while acknowledging that some expected growth inflection points have been delayed. • FY30 Growth Strategy: Management expects GenX data center opportunities, international bioenergy, CBG and bio-isobutanol to support progress toward its long-term revenue ambition, although achievement may be delayed. • Q2 Order Inflow: New order intake stood at ₹715 Cr, comprising 62% domestic and 38% international orders. • Q2 Order Mix: Bioenergy contributed 57% of new orders, engineering 26% and PHS 17%. • Order Book: Outstanding order backlog stood at approximately ₹4,460 Cr as of September 2026, with domestic orders contributing 63%. • Q2 Revenue Performance: Consolidated operating revenue stood at ₹849 Cr, compared with ₹842 Cr YoY. • Q2 Profit Before Tax: PBT increased to ₹36.1 Cr from ₹29.6 Cr YoY. • Q2 Net Profit: PAT increased to ₹23.1 Cr from ₹19.2 Cr YoY. • H1 Revenue Performance: Consolidated operating revenue stood at approximately ₹1,560 Cr, compared with ₹1,480 Cr YoY. • H1 EBIT Performance: EBIT increased to ₹57.1 Cr from ₹39.2 Cr YoY. • H1 Net Profit: PAT increased to ₹34.7 Cr from ₹24.62 Cr YoY. • Revenue Mix: Bioenergy contributed approximately 69% of revenue, engineering 21% and PHS 10%, while exports accounted for 38% of total revenue. • Cash Position: Company reported cash in hand of approximately ₹533 Cr as of September 30, 2026. • Key Challenges: Domestic ethanol project delays, customer financing constraints, slower conversion of order backlog into revenue, GenX capacity utilization, CBG project execution and policy-dependent commercialization of emerging biofuels remain important factors.
PRAJ INDUSTRIES LTD